TWiV reviews measles in Kenya, a trial for a intranasal COVID vaccine, dengue in the Florida Keys and in Central/South America, Spain connecting government with scientists, T cell activation and viral RNA fragments persist for up to 2 years after SARS-CoV-2 infection, and durable cross-reactive and protective antibodies against avian N2 neuraminidases elicited by A(H2N2) and A(H3N2) influenza pandemics.

Hosts: Vincent Racaniello and Alan Dove

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode * MicrobeTV Discord Server * Measles in Kenya (WHO) * Intranasal COVID vaccine trial (NIH) * Dengue in Florida Keys (Florida Health) * Dengue rising in Central/South America (NPR) * Spain to connect scientists with government (Science) * Persistence of T cells and viral RNA after SARS-CoV-2 infection (Sci Transl Med) * Influenza pandemics induce cross-reactive antibodies against avian N2 (Nat Comm) * Letters read on TWiV 1129 * Timestamps by Jolene. Thanks!

Weekly Picks Alan – The first few minutes of this video by Roger Barnes Vincent – Billy & Molly: An Otter Love Story

Listener Picks Fernando – A City on Mars

Intro music is by Ronald Jenkees

Send your virology questions and comments to twiv@microbe.tv